Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.32 6.67

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.33

Põhinäitajad

By Trading Economics

Sissetulek

2.6M

-5.5M

Müük

3M

38M

Aktsiakasum

-0.03

Kasumimarginaal

-14.573

Töötajad

128

EBITDA

2.1M

-5.5M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-36M

61M

Eelmine avamishind

-6.35

Eelmine sulgemishind

0.32

Uudiste sentiment

By Acuity

11%

89%

21 / 340 Pingereas Healthcare

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. aug 2026, 23:51 UTC

News

Enova International's subsidiary issued $300.89 million in notes, contributing to positive sentiment. The stock is higher in after-market trading, despite recent volatility.

21. aug 2026, 23:46 UTC

News

Home Depot expands roles for three executives, awarding $500,000 in stock grants. Shares were roughly flat during after-market hours following the announcement.

21. aug 2026, 23:41 UTC

News
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, bolstered by gains from UnitedHealth Group and Merck, despite broader market declines.

21. aug 2026, 23:36 UTC

News

Coty Inc reported a fourth-quarter revenue beat but issued weak guidance, resulting in shares trading lower in after-market hours.

21. aug 2026, 23:31 UTC

Correlated Moves
News

Ethereum's price reached $2,371 today, driven by anticipation of Pepeto's Binance listing and Bitcoin's rally past $79,000, boosting market sentiment.

21. aug 2026, 23:26 UTC

Correlated Moves
News

Citigroup Inc shares are lower during after-market hours, reflecting a slight decline amid broader market trends influenced by geopolitical tensions and bargain hunting.

21. aug 2026, 23:21 UTC

Correlated Moves
News
Social Media

Coinbase Global Inc is rising in after-market trading, supported by Bitcoin's significant gain. The company also launched a feature for immediate token access.

21. aug 2026, 23:06 UTC

News

Verizon Communications is deploying resources in response to a potential tropical storm in Hawaii, contributing to lower shares after Friday's close.

21. aug 2026, 23:06 UTC

Correlated Moves
News

KKR & Co Inc reported a net asset value of $8.49 billion as of July 31, contributing to positive sentiment in after-market trading.

21. aug 2026, 23:01 UTC

Social Media
News

Applied Optoelectronics Inc. plans to sell up to $600 million in shares, contributing to a decline in after-market trading amid dilution concerns.

21. aug 2026, 23:01 UTC

News

Hess Midstream LP shares are advancing in after-market trading following a dividend increase and improved free cash flow, despite lower EBITDA and net income.

21. aug 2026, 23:01 UTC

News

Texas Pacific Land Corp shares are higher in after-hours trading, with a market capitalization of $26.49 billion reflecting strong long-term performance.

21. aug 2026, 23:01 UTC

News
Social Media

Sigma Lithium Corp resumes full operations under a new agreement in Brazil, targeting 240,000 tonnes of lithium oxide concentrate. Shares are advancing in after-market trading.

21. aug 2026, 23:01 UTC

News

Spectrum Brands Holdings Inc shares are higher in after-market trading. The company expects low-single-digit revenue growth for fiscal year 2026 amid ongoing cost pressures.

21. aug 2026, 22:01 UTC

News

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

21. aug 2026, 20:07 UTC

News
Social Media

Microsoft shares are higher, supported by bullish options activity and a reaffirmed AAA rating from Moody's. The company is part of a $615 billion AI investment group.

21. aug 2026, 20:07 UTC

Social Media
News

Palantir Technologies shares are higher today amid increased options trading and positive sentiment, with Deutsche Bank reiterating a $200 price target.

21. aug 2026, 20:07 UTC

News

Aflac shares are lower today as Japan Post sold 12,700 shares, contributing to negative sentiment amid broader market declines since Thursday's close.

21. aug 2026, 20:07 UTC

News

United Parcel Service shares are trading lower as Zacks cuts Q3 EPS estimate to $1.60. Susquehanna raises target price to $120, maintaining a neutral rating.

21. aug 2026, 20:07 UTC

News

Barclays maintains an Overweight rating on Hims & Hers Health, lowering its price target to $35. Shares are trading higher amid positive market sentiment.

21. aug 2026, 20:07 UTC

News
Correlated Moves

The USD/SEK is trading lower today, continuing a decline since Thursday's close. Earlier in the session, the dollar rebounded from a session low.

21. aug 2026, 20:06 UTC

News

Nu Holdings is higher today, buoyed by a rise in Bitcoin prices following the U.S. Treasury's announcement to double long-dated bond buybacks.

21. aug 2026, 20:06 UTC

News
Correlated Moves

Gold prices are rising, reaching a near three-month high, driven by U.S. Treasury bond buybacks and President Trump's shift in Iran policy.

21. aug 2026, 20:06 UTC

Correlated Moves
News

First Western Financial promotes Brian Weldon to Regional President and Bryce Parietti and Rob Miles to Market Presidents, with shares trading higher today.

21. aug 2026, 20:06 UTC

News

Liquidity Services shares are higher after announcing CEO Bill Angrick's presentation at the Midwest IDEAS Investor Conference on August 26, 2026, in Chicago.

21. aug 2026, 20:06 UTC

News

Palo Alto Networks shares are higher following multiple analyst price target increases, including Cantor Fitzgerald's raise to $425 from $340.

21. aug 2026, 20:06 UTC

News

Citizens Inc shares are lower today, continuing a decline since Thursday amid broader market downturns. The stock remains below its 20-day moving average.

21. aug 2026, 20:06 UTC

News
Social Media

Stoke Therapeutics shares rise following analyst reinstatement with Overweight rating and $40 price target, amid positive sentiment for zorevunersen’s phase III EMPEROR trial.

21. aug 2026, 20:06 UTC

News

T Rowe Price shares are lower as the company pursues its acquisition of F/M Investments, which manages over $10 billion in ETF assets.

21. aug 2026, 20:06 UTC

News

Salesforce Inc is higher as investor interest grows ahead of its August 26 earnings report, with a revenue target of $11.3 billion for Q2.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

21 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat